Skip to main content

Day: July 6, 2020

Atos dévoile les tendances et technologies qui vont façonner les entreprises et la société d’ici 2024

Paris, le 6 juillet 2020 – Atos, un leader global de la transformation digitale, dévoile sa vision de l’évolution du monde des affaires, de la société et des technologies dans sa dernière publication Thought Leadership « Journey 2024 – Redéfinir la raison d’être de l’entreprise ». Le rapport anticipe les tendances technologiques et business qui devraient apporter des ruptures majeures et façonner les entreprises au cours des quatre prochaines années. Il s’appuie sur les recherches approfondies menées par la communauté scientifique d’Atos, un réseau mondial de 160 scientifiques de premier plan issus de l’ensemble du groupe.Redéfinir la raison d’être de l’entreprise d’après COVIDL’après-COVID est une période fortement synonyme d’incertitudes et annonciatrice de changements majeurs pour...

Continue reading

Changes in Coop Pank AS articles of association

On 28 May 2020, the general meeting of shareholders of Coop Pank AS (registry code 10237832) resolved to amend the articles of association of Coop Pank AS and to adopt the new version of them.Today, on 6 July 2020 the amended articles of association were registered at the Estonian Commercial Register and the new articles of association entered into force.The articles of association is attached to this stock exchange announcement and is also available on the webpage of Coop Pank AS on https://www.cooppank.ee/en/investorile.Coop Pank, based on Estonian capital, is one of the five universal banks operating in Estonia. The number of clients using Coop Pank for their daily banking is 72 800. Coop Pank aims to put the synergy generated by the interaction of retail business and banking to good use and to bring everyday banking services closer...

Continue reading

Muudatused Coop Pank AS-i põhikirjas

Coop Pank AS-i (registrikood 10237832) aktsionäride üldkoosolek otsustas 28.05.2020 muuta Coop Pank AS põhikirja ja kinnitada see uues redaktsioonis.Täna, 06.07.2020 registreeriti muudetud põhikiri Äriregistris ning uus põhikiri on seega jõustunud.Põhikiri on lisatud käesolevale börsiteatele ning kättesaadav Coop Pank AS-i veebileheküljel https://www.cooppank.ee/investorile.Eesti kapitalil põhinev Coop Pank on üks viiest Eestis tegutsevast universaalpangast. Pangal on 72 800 igapäevapanganduse klienti. Coop Pank kasutab jaekaubanduse ja panganduse vahel tekkivat sünergiat ning toob igapäevased pangateenused inimeste kodu lähedale. Panga strateegiliseks aktsionäriks on kodumaine kaubanduskett Coop Eesti, mille müügivõrgustikku kuulub 330 kauplust.Lisainfo:Kristjan Seema Turundus- ja kommunikatsioonijuht +372 5505 253 kristjan.seema@cooppank.eeManusCoop...

Continue reading

Construction contract (Maarjamõisa Medical Campus phase III)

Tartu University Hospital has signed a contract with joint bidders Nordecon AS and its subsidiary Embach Ehitus OÜ for the construction of phase III of Maarjamõisa Medical Campus. During the phase III two new wings for L.Puusepa 8 buildings complex will be built – wing M for new children hospital and wing C for ear clinic, family center of women’s clinic and ambulatory surgery.Wing M will be built as an extension to wing H, accommodating six above-ground and two below-ground floors, including parking. Total gross area of the building will be around 20,000 sqm. New wing C will have four above-ground and one below-ground floor with total gross space of about 13,600 sqm.The cost of the construction is 47.3 million euros, plus VAT. Construction works will begin in July 2020 and will last for about two years.Nordecon (www.nordecon.com)  is...

Continue reading

Ehituslepingu sõlmimine (Maarjamõisa meditsiinilinnaku III etapp)

Sihtasutus Tartu Ülikooli Kliinikum sõlmis Maarjamõisa meditsiinilinnaku III etapi ehitustööde peatöövõtulepingu AS-ga Nordecon, kes osales hankel ühispakkumisega koos tütarettevõttega Embach Ehitus. Meditsiinlinnaku III ehitusjärgus ehitatakse L. Puusepa 8 hoonete kompleksile juurde kaks uut korpust – M-korpus, millest saab uus lastehaigla, ning uus C-korpus kõrvakliiniku, naistekliiniku perekeskuse ning päevakirurgia jaoks.M-korpus hakkab paiknema H-korpuse jätkuna, mahutades kuus maapealset ning kaks maa-alust korrust koos parklaga. Kogu uusehitise brutopinna suurus on ligikaudu 20 000m2. Uus C-korpus ehitakse nelja maapealse ning ühe maa-aluse korrusega ning kogu korpuse brutopind on ligikaudu 13 600m2.Lepingu maksumuseks on 47,3 miljonit eurot, millele lisandub käibemaks. Ehitustööd algavad juulis 2020 ning kestavad ligikaudu kaks...

Continue reading

Rio Silver Provides Update on Palta Dorada Gold-Silver-Copper Project, Peru

VANCOUVER, British Columbia, July 06, 2020 (GLOBE NEWSWIRE) — Rio Silver Inc. (“Rio Silver” or the “Company”) (TSX.V: RYO)  is pleased to announce that the Company has been notified by its partner, Peruvian Metals Corp. (“Peruvian Metals”), that Peruvian Metals plans to initiate an exploration and bulk sampling program on the high grade Au-Ag-Cu Palta Dorada project (“Palta Dorada” or the “Property”) early in the third quarter. The Company signed a Memorandum of Understanding (“MOU”) with Peruvian Metals in early January 2020 (see The Company’s news release January 9th) to jointly explore the Property by conducting a detailed sampling and mapping program along with a bulk sampling campaign. Under the MOU, Peruvian Metals is required to provide the upfront capital to start the program and has also informed Rio...

Continue reading

Aktietilbagekøb i Danske Andelskassers Bank A/S – transaktioner i uge 27

Den 1. oktober iværksatte Danske Andelskassers Bank A/S’ (”Banken”) et aktietilbagekøbsprogram. Aktietilbagekøbsprogrammet løber i perioden fra 1. oktober 2019 til 30. september 2020. I denne periode vil Banken opkøbe aktier for en maksimal værdi af 16.898.800 kroner, jf. selskabsmeddelelse nr. 18 af 24. september 2019.Efter ovenstående transaktioner ejer Banken i alt 1.984.259 egne aktier svarende til 1,0673 % af Bankens aktiekapital.Siden aktietilbagekøbsprogrammet blev iværksat den 1. oktober 2019, er der samlet købt 2.315.303 aktier for et samlet beløb på 16.532.823 kroner.Alle transaktioner er foretaget i ISIN DK0060299063.Vedhæftet fil43 – 2020 Selskabsmeddelelse_Aktietilbagekøb uge 27

Continue reading

Advantest Opens myAdvantest, an Online Portal Providing 24/7 Access to Digital Products and Web-Based Services

TOKYO, July 06, 2020 (GLOBE NEWSWIRE) — Leading semiconductor test equipment supplier Advantest Corporation (TSE: 6857) has introduced a new online portal enabling customers to place orders and get instant delivery of Advantest’s cloud-based services and software products, making these items available on demand, anytime and anywhere.  Users can access the myAdvantest portal from any internet-connected device without having to install an app or software program.One of the portal’s initially available services is interactive online training.  Dojo™, the Advantest Online Training System, is a cloud-based eLearning service.  In addition to offering self-paced, interactive multimedia courses, Dojo also offers unlimited access to a virtual SmarTest Software Playground environment for practicing and executing lab simulation tests as well...

Continue reading

Præcisering af forventninger til omsætning og driftsresultat

MEDDELELSE NR. 194 ChemoMetec præciserer forventningerne til omsætningen og driftsresultatet for regnskabsåret 2019/20 som omfatter perioden 1. juli 2019 til 30. juni 2020.På baggrund af de foreløbige regnskabstal forventes ChemoMetec at omsætte omkring DKK 214 mio, mod tidligere udmeldt DKK 205-213 mio. Samtidig forventes et driftsresultat (EBITDA) på omkring DKK 90 mio. mod tidligere udmeldt DKK 82-90 mio.ChemoMetecs årsrapport for 2019/20 forventes offentliggjort torsdag den 17. september 2020.Yderligere oplysningerAdm. direktør (CEO) Steen Søndergaard, ChemoMetec A/S,Telefon: (+45) 4813 1020Om ChemoMetec A/SChemoMetec udvikler, producerer og markedsfører analyseinstrumenter til celletælling og en lang række andre målinger. ChemoMetecs analyseinstrumenter markedsføres globalt inden for blandt andet pharma, biotek og landbrug. ChemoMetec...

Continue reading

Formpipe acquires the British company EFS

Formpipe acquires EFS Technology Ltd. (EFS), which for many years has been a successful sales partner for Formpipe’s Lasernet product. With the deal, Formpipe is increasing its capacity to build a larger network of competent partners in the private sector. EFS revenue for 2019 amounted to GBP 3.4 million.Formpipe acquires 100% of the shares in EFS. The acquisition is expected to be completed by July 31. The purchase price amounts to GBP 6 million (equivalent to an estimated Enterprise Value of approximately GBP 5 million), which is paid in connection with the takeover and is financed through a combination of own cash and loans. EFS’s turnover for the financial year 2019 amounted to GBP 3.4 million, of which just over half consists of recurring revenue from support and maintenance agreements. The acquisition is expected to...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.